- Public Comps
- Agfa-Gevaert
Agfa-Gevaert Valuation Multiples
Discover Agfa-Gevaert's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Saluda Medical, Zomedica, Hyperfine, Creo Medical Group and more.
Agfa-Gevaert Overview
About Agfa-Gevaert
Agfa-Gevaert NV develops, produces, and distributes a range of analog and digital imaging systems and information technology solutions, for the printing sector, healthcare sector, and specific industrial applications. The company's operating segment includes CONOPS; Digital Print and Chemicals; Radiology Solutions and Healthcare IT. It generates maximum revenue from the Digital Print and Chemicals segment. The company operates in Europe, NAFTA, Latin America and Asia/Oceania/Africa.
Founded
1964
HQ

Employees
4.8K
Website
Financials (LTM)
EV
$234M
Valuation Multiples
Start free trialAgfa-Gevaert Financials
Agfa-Gevaert reported last 12-month revenue of $1.2B and EBITDA of $69M.
In the same LTM period, Agfa-Gevaert generated $372M in gross profit, $69M in EBITDA, and had net loss of ($24M).
Revenue (LTM)
Agfa-Gevaert P&L
In the most recent fiscal year, Agfa-Gevaert reported revenue of $1.3B and EBITDA of ($8M).
Agfa-Gevaert is unprofitable as of last fiscal year, with gross margin of 30%, EBITDA margin of (1%), and net margin of (7%).
Financial data powered by Morningstar, Inc.
Agfa-Gevaert Stock Performance
Agfa-Gevaert has current market cap of $84M, and enterprise value of $234M.
Market Cap Evolution
Agfa-Gevaert's stock price is $0.55.
Agfa-Gevaert share price decreased by 0.5% in the last 30 days, and by 50.2% in the last year.
Agfa-Gevaert has an EPS (earnings per share) of $-0.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $234M | $84M | -0.5% | -0.5% | 11.7% | -50.2% | $-0.53 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAgfa-Gevaert Valuation Multiples
Agfa-Gevaert trades at 0.2x EV/Revenue multiple, and 3.4x EV/EBITDA.
EV / Revenue (LTM)
Agfa-Gevaert Financial Valuation Multiples
As of September 2, 2026, Agfa-Gevaert has market cap of $84M and EV of $234M.
Agfa-Gevaert has a P/E ratio of (3.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Agfa-Gevaert Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Agfa-Gevaert Margins & Growth Rates
Agfa-Gevaert decreased revenue by 1% and EBITDA by 950% in the last fiscal year.
In the most recent fiscal year, Agfa-Gevaert reported gross margin of 30%, EBITDA margin of (1%), and net margin of (7%).
Agfa-Gevaert Margins
Agfa-Gevaert Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Agfa-Gevaert Operational KPIs
Agfa-Gevaert's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Agfa-Gevaert's Rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Agfa-Gevaert's Rule of X is 2% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Agfa-Gevaert Competitors
Agfa-Gevaert competitors include Saluda Medical, Zomedica, Hyperfine, Creo Medical Group, Sera Prognostics, Allianca Saude, electroCore, PWO, INIFY Laboratories and CVRx.
Most Agfa-Gevaert public comparables operate across Medical Devices, Industrial Parts, Medical Imaging & Diagnostics, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | - | - | |||
| 1.3x | 1.3x | (0.5x) | - | |||
| 4.1x | 3.1x | (1.6x) | (1.7x) | |||
| 9.2x | 6.9x | (3.3x) | (4.7x) | |||
| 476.7x | 217.3x | (1.1x) | (1.2x) | |||
| 1.0x | - | (1.0x) | - | |||
| 2.5x | 2.1x | (6.8x) | (12.8x) | |||
| 0.3x | 0.3x | 2.8x | 3.3x | |||
This data is available for Pro users. Sign up to see all Agfa-Gevaert competitors and their valuation data. Start Free Trial | ||||||
Investments by Agfa-Gevaert
Agfa-Gevaert has invested in 1 company to date.
Latest investment by Agfa-Gevaert was on September 5th 2023. Agfa-Gevaert invested in Penny Black in their $2M Seed round (EV/Revenue multiple available to Pro users).
Latest Investments by Agfa-Gevaert
| Description | Penny Black is a direct-mail marketing platform that integrates personalized print materials into e-commerce order fulfillment. The service enables brands to insert custom flyers and campaigns during pick-and-pack, leveraging unboxing moments for customer retention. London-based, it guarantees 100 percent open rates through physical postcards added to shipments from warehouses worldwide. | Penny Black is a direct-mail marketing platform that integrates personalized print materials into e-commerce order fulfillment. The service enables brands to insert custom flyers and campaigns during pick-and-pack, leveraging unboxing moments for customer retention. London-based, it guarantees 100 percent open rates through physical postcards added to shipments from warehouses worldwide. | Penny Black is a direct-mail marketing platform that integrates personalized print materials into e-commerce order fulfillment. The service enables brands to insert custom flyers and campaigns during pick-and-pack, leveraging unboxing moments for customer retention. London-based, it guarantees 100 percent open rates through physical postcards added to shipments from warehouses worldwide. | Penny Black is a direct-mail marketing platform that integrates personalized print materials into e-commerce order fulfillment. The service enables brands to insert custom flyers and campaigns during pick-and-pack, leveraging unboxing moments for customer retention. London-based, it guarantees 100 percent open rates through physical postcards added to shipments from warehouses worldwide. |
| HQ Country | ||||
| HQ City | London | London | London | London |
| Deal Date | 5 Sep 2023 | 25 Oct 2022 | 1 Oct 2021 | 1 Apr 2021 |
| Round | Seed | Seed | Seed | Pre-seed |
| Raised | $2M | $2M | $2M | $500K |
| Investors | Agfa-Gevaert; Ninepointfive | Agfa-Gevaert; Ninepointfive | Agfa-Gevaert; Ninepointfive | Agfa-Gevaert; Ninepointfive |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all Agfa-Gevaert investments and their VC round multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Agfa-Gevaert
| Who are competitors of Agfa-Gevaert? | Agfa-Gevaert main competitors include Saluda Medical, Zomedica, Hyperfine, Creo Medical Group, Sera Prognostics, Allianca Saude, electroCore, PWO, INIFY Laboratories, CVRx. |
See public comps similar to Agfa-Gevaert
Lists including Agfa-Gevaert
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





